K192072

Substantially Equivalent

Tina-quant C-Reactive Protein IV

Applicant: Roche Diagnostics Operations (Rdo)
Product code: DCN
Advisory panel: Immunology
Date received: 2019-08-02
Decision date: 2020-02-21
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Indianapolis, IN, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.